J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 40,000 shares at $16.11 ($643K) on 2019-04-17, disclosed to the SEC on 2019-04-19.
Open-market sale of $643k FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.11 | 1,092 | $18K | 2.7% |
| 2 | $16.11 | 1,092 | $18K | 2.7% |
| 3 | $16.18 | 7,449 | $121K | 18.7% |
| 4 | $16.18 | 7,449 | $121K | 18.7% |
| 5 | $16.01 | 6,843 | $110K | 17.0% |
| 6 | $16.01 | 6,843 |
| $110K |
| 17.0% |
| 7 | $16.02 | 4,616 | $74K | 11.5% |
| 8 | $16.02 | 4,616 | $74K | 11.5% |
| Total | $16.08 avg | 40,000 | $643K | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |